The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of MEDI0457 and durvalumab for patients with recurrent/metastatic HPV-associated cancers.
 
Van K. Morris
Honoraria - Projects in Knowledge
Consulting or Advisory Role - Array Biopharma; Axiom Healthcare Strategies; Bicara Therapeutics; BioMedical Insights; Boehringer Ingelheim; Incyte; SERVIER
Research Funding - BioNTech (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); EMD Serono (Inst); Immatics; Pfizer (Inst)
 
Amir A. Jazaeri
Stock and Other Ownership Interests - Avenge Bio
Honoraria - Gerson Lehrman Group; Guidepoint Global; Mosaic Research Management
Consulting or Advisory Role - Agenus; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; integrity Continuing Education; Iovance Biotherapeutics; Macrogenics; NuProbe; twoXAR
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); ZIOPHARM Oncology (Inst)
 
Shannon Neville Westin
Consulting or Advisory Role - AstraZeneca; BioAscent; Casdin Capital; Circulogene Theranostics; Clovis Oncology; Curio Science; Curio Science; Eisai; Genentech; Gerson Lehrman Group; GlaxoSmithKline; Medscape; Merck; Novartis; OncLive; Pfizer; Roche; Targeted Oncology; Tesaro; Vaniam Group; Watermark Research Partners; Zentalis
Research Funding - ArQule; AstraZeneca; Bayer; Celgene (I); Clovis Oncology; Cotinga Pharmaceuticals; GOG Foundation (Inst); Karyopharm Therapeutics (I); Kite, a Gilead company (I); Novartis; Roche/Genentech; Tesaro
 
Curtis Alvin Pettaway
Consulting or Advisory Role - Wolters Kluwer
Research Funding - Beckman Coulter; MDxHealth
 
Solly George
No Relationships to Disclose
 
Ryan Huey
No Relationships to Disclose
 
Michaela Onstad
No Relationships to Disclose
 
Shi-Ming Tu
Consulting or Advisory Role - Janssen Biotech
 
Jennifer Wang
No Relationships to Disclose
 
Aaron Shafer
No Relationships to Disclose
 
Benny Johnson
Consulting or Advisory Role - Gritstone Bio; Incyte; Syntrix Biosystems; Taiho Oncology
Research Funding - Bristol-Myers Squibb
 
Lianchun Xiao
No Relationships to Disclose
 
David J Vining
No Relationships to Disclose
 
Ming Guo
No Relationships to Disclose
 
Ying Yuan
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - Abbvie; Amgen; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene/Juno; MicuRx Pharmaceuticals; SERVIER; Starpax Medical; Vertex
 
Michael M. Frumovitz
Consulting or Advisory Role - Biom'up; Stryker
Speakers' Bureau - Stryker
Research Funding - AstraZeneca/MedImmune; Stryker